Safety and Immunogenicity of Skyvaricella Injection in Healthy Volunteer Vietnamese Children From 12 Months to 12 Years Old

计划入组 201 人 · 首次发布于 2020 年 5 月 12 日

AI in SK Histopathological Diagnosis

计划入组 30 人 · 首次发布于 2026 年 8 月 26 日

A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403

计划入组 30 人 · 首次发布于 2010 年 5 月 26 日

SK Japanese Encephalitis MRNA Vaccines(Sk Bioscience)

GBP510 adjuvanted with Alum(SK Bioscience)

Next-generation pneumococcal conjugate vaccine (Sanofi/SK Bioscience)

SK bioscience Co., Ltd.

South Korea

SK Life Science, Inc.

United States

SK Plasma Co., Ltd.

South Korea

SK Bioscience Wins Appeal Against Pfizer in Pneumococcal Vaccine Patent Dispute

SK Bioscience Partners with Colombia on $260 Million Vaccine Manufacturing Initiative

SK Bioscience Secures Landmark Victory Against Moderna in Korean mRNA Patent Dispute